Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | ONYX Onyx Biotec Ltd. Pharma · SME | BALAXI BALAXI PHARMACEUTICALS LIMITED Pharma · Small | BALPHARMA Bal Pharma Limited Pharma · Small | JFLLIFE JFL Life Sciences Ltd. Pharma · SME |
|---|---|---|---|---|
| Final Score | 15 | 10 | 19 | 65 |
| Verdict | OVERVALUED | OVERVALUED | OVERVALUED | UNDERVALUED |
| Style | OVERVALUED | OVERVALUED | Distress Watch | Deep Value |
| Piotroski | 3/9 | 3/9 | 6/9 | 6/9 |
| Valuation | 6/30 | 4/30 | 7/30 | 26/30 |
| Growth | 7/25 | 1/25 | 8/25 | 21/25 |
| Quality | 0/20 | 0/20 | 0/20 | 12/20 |
| Balance Sheet | 9/15 | 10/15 | 0/15 | 9/15 |
| Cash Flow | 0/10 | 1/10 | 9/10 | 1/10 |
| Price | ₹42 | ₹24.22 | ₹87.79 | ₹9.9 |
| P/E | — | 95.20 | 21.60 | 10.30 |
| P/B | 1.41 | 0.54 | 1.65 | 1.44 |
| ROE | -0.38% | 0.59% | 7.87% | 15.00% |
| ROCE | 1.14% | 3.11% | 9.69% | 18.20% |
| Debt / Equity | 0.27 | 0.23 | 1.95 | 0.48 |
| FCF Yield | — | — | 6.67% | — |
| Dividend Y | — | — | 1.41% | — |
| Altman Z | 2.78 | 3.06 | 1.71 | 2.60 |
| Promoter % | 65.10% | 65.99% | 50.87% | 67.47% |
| Mkt Cap (₹Cr) | 78.00 | 135.00 | 135.00 | 66.00 |
| Graham # | — | ₹16.24 | ₹67.63 | ₹12.32 |
| Fair PE | 23.5 | 0.9 | 16.1 | 42.0 |
| MoS % | — | -10731.4% | -38.7% | +75.7% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startONYX74
BALAXI28
BALPHARMA71
JFLLIFE25